Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Cyclerion Therapeutics, Inc. (CYCN) had Cash Flow from Financial Activities of $0.82M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.75M |
|
-- |
|
-- |
|
$1.77M |
|
$-1.77M |
|
$0.02M |
|
$-1.75M |
|
$-1.75M |
|
$-1.75M |
|
$-1.75M |
|
$-1.75M |
|
$-1.75M |
|
$-1.77M |
|
$-1.77M |
|
4.25M |
|
4.25M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$1.51M |
|
$0.07M |
|
$5.42M |
|
$6.93M |
|
$1.84M |
|
-- |
|
-- |
|
$1.84M |
|
$5.09M |
|
$5.09M |
|
$5.09M |
|
4.26M |
|
| Cash Flow Statement Financials | |
$-2.61M |
|
$-0.07M |
|
|
Cash Flow from Financial Activities |
$0.82M |
$3.24M |
|
$1.39M |
|
$-1.85M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.50% |
|
-34.50% |
|
-25.32% |
|
-34.50% |
|
$1.20 |
|
$-0.63 |
|
$-0.61 |
|